If youre a clinician considering microdosing: Be explicit: We dont know exactly how or why this might work at this dose Consider it especially for: Normal-weight patients with metabolic dysfunction Patients who cant tolerate higher doses Conditions with strong mechanistic rationale (PCOS, autoimmune disease, addiction) Monitor objectively: weight and body composition, waist circumference, labs, symptom scores, not just subjective reports Track patients who dont lose weight but report benefits - these are your most interesting cases Document everything, contribute to registries If youre a patient considering microdosing: Understand that benefits without weight loss are reported but not proven Know that you might be benefiting from small amounts of visceral fat loss that dont show on your scale Be skeptical of your own subjective improvement (placebo is real) Know that all medications come with possible side effects Work with a clinician who will help you figure out if its actually working If youre a researcher: Please study the minimal effective dose Use imaging to measure visceral fat, not just scale weight Design studies in normal-weight metabolically unhealthy individuals Compare weight-matched groups to isolate non-weight-loss effects My opinion

Who Should (and Shouldnt) Use GLP-1 Antagonists for Weight Loss
GLP-1 receptor agonists work by mimicking the naturally occurring hormone glucagon-like peptide-1, which slows gastric emptying, increases satiety, and reduces appetite
It improves insulin sensitivity so your body processes glucose more efficiently
Read our article on key strength training techniques here .) 4
It is important to approach this question carefully, distinguishing between what clinical trial data has formally reported, what has been observed anecdotally, and what remains biologically plausible but unconfirmed